BioSpace News Archive

--Integrating 3D genomics with publicly available, genome-wide genetic data, researchers uncovered genetic correlations between IBD, stress, and depression--

Advanced Chemotherapy Technologies, Inc., a clinical-stage drug delivery company, announced today that it has closed a $5.5 million Series A investment round led by Khosla Ventures. The capital will be used to fund initial clinical development of the company’s ACT-IOP-003 local chemotherapy system for the treatment of local

Protalix BioTherapeutics, Inc. (NYSE American: PLX) (TASE: PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx ® plant cell-based protein expression system, today announced that it has rescheduled today’s conferenc

BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company developing a proprietary biomedical signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, today announced that the Company installed its PURE EP™ System and started conducting patient cases at Deborah Heart and Lung Center in Browns Mills, New Jersey. PURE EP™ System evaluation a

Partnership Will Accelerate the Awareness and Adoption of Precision Oncology in Private Practices and Community Oncology Cancer Centers in the United States

Cryoport, Inc., a global leader in life sciences solutions, announced that the Company will report financial results for the third quarter ended September 30, 2020 on Thursday, November 5, 2020 after U.S. markets close.

Advanced diagnostics company Prime Genomics, announced former DigitalDx EIR Robert Weigle joins as CEO, bringing over 25 years of experience building healthcare businesses.

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the company was once again ranked as the top company to work for by Science magazine in its annual Top Employers Survey of the global biotech and pharmaceutical industry.

Pharmaceutical Technology® and BioPharm International® are pleased to announce their first-ever 2020 Bio/Pharma Virtual Congress, taking place Wednesday, Nov. 11, from 8:30 a.m. to 4 p.m. EST.

In a recent preprint, scientists at Stanford, Oxford, and the Broad Institute leveraged 3.6 million anonymous health data submissions from Enya.ai’s FeverIQ to demonstrate how secure multiparty computation (SMC) can optimize for Covid-19 symptom screening without compromising user privacy.